Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

There has been a tremendous growth in percutaneous coronary interventions (PCIs) with stent implantation, even in cases where coronary artery bypass grafting (CABG) demonstrates superior long-term ...

PARIS, France—It’s not a stent in a traditional sense, nor a scaffold that completely disappears over time, but a new device—one that “unchains” itself over time—has cleared an early hurdle by proving ...

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

XIENCE Xpedition™ 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents Has the Potential to Reduce Overall Procedural Costs Very Long Lesions Most Often Seen in ...

Mar. 24 -- FRIDAY, Feb. 22 (HealthDay News) -- To stent or not to stent? Which type of the artery-opening device is best? When is heart bypass surgery smarter than getting a stent? These are the ...

In one of the longest studies to date in high-risk heart disease, researchers found no significant difference in death rates over more than 10 years—as well as in cases of heart attack or ...

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...

The medical literature contains a huge number of studies on the safety and performance of novel stent platforms, with primary outcomes usually assessed at 6 months or 1 year. The 5-year analysis from ...

Researchers at the NIH and Emory School of Medicine have completed the first minimally invasive coronary artery bypass of the ...

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market: Size, Trends & Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering. Global Coronary Stents Market: Size, ...